Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Orion Corporation: Managers' transactions - Satu Ahomäki

Posted on: 02 Mar 18

ORION CORPORATION           MANAGERS' TRANSACTIONS 2nd of March 2018 at 9.45 EET             

Orion Corporation: Managers' transactions - Satu Ahomäki

Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons.

Person subject to the notification requirement
Name: Ahomäki, Satu  
Position: Other senior manager
Initial Notification  
Reference number: 74370029VAHCXDR7B745_20180301120952_3
Name: Orion Oyj
LEI: 74370029VAHCXDR7B745
Transaction details
Transaction date: 2018-03-01
Nature of the transaction: Receipt of a Share-Based Incentive or Remuneration
Instrument: Share
ISIN: FI0009014377
Volume: 6729
Unit price: 0.00000 Euro
Aggregated transactions
Volume: 6729
Volume weighted average price: 0.00000 Euro

Orion Corporation

Timo Lappalainen Olli Huotari
President and CEO    SVP, Corporate Functions


Orion Corporation
Orionintie 1A, FI-02200 Espoo


Last updated on: 02/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.